Oncolytic activity of HF10 in head and neck squamous cell carcinomas

Recent developments in therapeutic strategies have improved the prognosis of head and neck squamous cell carcinoma (HNSCC). Nevertheless, 5-year survival rate remains only 40%, necessitating new therapeutic agents. Oncolytic virotherapy entails use of replication-competent viruses to selectively kil...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Gene Ther
Päätekijät: Esaki, Shinichi, Goshima, Fumi, Ozaki, Haruka, Takano, Gaku, Hatano, Yoshimi, Kawakita, Daisuke, Ijichi, Kei, Watanabe, Takahiro, Sato, Yoshitaka, Murata, Takayuki, Iwata, Hiromitsu, Shibamoto, Yuta, Murakami, Shingo, Nishiyama, Yukihiro, Kimura, Hiroshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group US 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445880/
https://ncbi.nlm.nih.gov/pubmed/31477804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-019-0129-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia